GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Accolade Inc (NAS:ACCD) » Definitions » Gross Profit

Accolade (Accolade) Gross Profit : $192.1 Mil (TTM As of Feb. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Accolade Gross Profit?

Accolade's gross profit for the three months ended in Feb. 2024 was $66.6 Mil. Accolade's gross profit for the trailing twelve months (TTM) ended in Feb. 2024 was $192.1 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Accolade's gross profit for the three months ended in Feb. 2024 was $66.6 Mil. Accolade's Revenue for the three months ended in Feb. 2024 was $124.8 Mil. Therefore, Accolade's Gross Margin % for the quarter that ended in Feb. 2024 was 53.38%.

Accolade had a gross margin of 53.38% for the quarter that ended in Feb. 2024 => Durable competitive advantage

During the past 7 years, the highest Gross Margin % of Accolade was 46.36%. The lowest was 30.45%. And the median was 45.01%.


Accolade Gross Profit Historical Data

The historical data trend for Accolade's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accolade Gross Profit Chart

Accolade Annual Data
Trend Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Gross Profit
Get a 7-Day Free Trial 58.82 76.69 141.00 164.24 192.06

Accolade Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.98 39.02 41.55 44.85 66.64

Competitive Comparison of Accolade's Gross Profit

For the Health Information Services subindustry, Accolade's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accolade's Gross Profit Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Accolade's Gross Profit distribution charts can be found below:

* The bar in red indicates where Accolade's Gross Profit falls into.



Accolade Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Accolade's Gross Profit for the fiscal year that ended in Feb. 2024 is calculated as

Gross Profit (A: Feb. 2024 )=Revenue - Cost of Goods Sold
=414.292 - 222.232
=192.1

Accolade's Gross Profit for the quarter that ended in Feb. 2024 is calculated as

Gross Profit (Q: Feb. 2024 )=Revenue - Cost of Goods Sold
=124.831 - 58.194
=66.6

Gross Profit for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $192.1 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Accolade's Gross Margin % for the quarter that ended in Feb. 2024 is calculated as

Gross Margin % (Q: Feb. 2024 )=Gross Profit (Q: Feb. 2024 ) / Revenue (Q: Feb. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=66.6 / 124.831
=53.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Accolade  (NAS:ACCD) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Accolade had a gross margin of 53.38% for the quarter that ended in Feb. 2024 => Durable competitive advantage


Accolade Gross Profit Related Terms

Thank you for viewing the detailed overview of Accolade's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Accolade (Accolade) Business Description

Traded in Other Exchanges
Address
1201 Third Avenue, Suite 1700, Seattle, WA, USA, 98101
Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.
Executives
Richard Eskew officer: EVP General Counsel C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Stephen H. Barnes officer: Chief Financial Officer C/O ACCOLADE, INC., 660 WEST GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Rajeev Singh director, officer: Chief Executive Officer 6222 185TH AVENUE NE, REDMOND WA 98052
Robert N Cavanaugh officer: President 1601 CLOVERFIELD BLVD., SUITE 620, SANTA MONICA CA 90404
Mchugh Colin officer: Chief Accounting Officer C/O ACCOLADE, INC., 660 W. GERMANTOWN PIKE, SUITE 500, PLYMOUTH MEETING PA 19462
Michael W Hilton officer: Chief Product Officer 6222 185TH AVE, REDMOND WA 98052
Peter S Klein director C/O MICROSOFT CORPORATION, ONE MICROSOFT WAY, REDMOND WA 98052-6399
Cindy Kent director 7601 PENN AVENUE SOUTH, RICHFIELD MN 55418
Patricia L Wadors director C/O ALIGN TECHNOLOGY INC, 881 MARTIN AVE, SANTA CLARA CA 95050
Dawn G Lepore director 1425 BROADWAY PMB 41, SEATTLE WA 99122
Jeffrey D Jordan director 2865 SAND HILL ROAD #101, MENLO PARK CA 94025
Elizabeth G Nabel director BRIGHAM AND WOMEN'S HOSPITAL, 75 FRANCIS ST, BOSTON MA 02115
Jeffrey S Brodsky director C/O MORGAN STANLEY 1585 BROADWAY, NEW YORK NY 10036
Thomas J Neff director SPENCER STUART & ASSOCIATES, 277 PARK AVE, NEW YORK NY 10172
William H. Frist director 600 MONTGOMERY STREET, SAN FRANCISCO CA 94111

Accolade (Accolade) Headlines